Nexalin Technology NXL
NASDAQ NXL
$4.85 -0.20 (-3.84%)
As of: Sep 10, 2026 · 12:03 PM EDT

Nexalin Technology (NXL) Operating Income (2021 - 2026)

Nexalin Technology (NXL) posted Operating Income of -$2.2 million for Q2 2026, down 6.01% on a QoQ basis from -$2.1 million in Q1 2026, and down 38.65% year-over-year from -$3.7 million in Q2 2025.

Analysis

Nexalin Technology (NXL) Operating Income (2021 - 2026) Analysis & Trends

Nexalin Technology has reported Operating Income for 6 years, with the latest figure at -$2.2 million in Q2 2026.

  • On a quarterly basis, Operating Income fell 38.65% year-over-year to -$2.2 million in Q2 2026; TTM through Jun 2026 was -$9.1 million, a 1.22% decrease from a year earlier, with the FY2025 full-year figure at -$8.4 million, down 8.2% from the prior year.
  • Operating Income was -$2.2 million for Q2 2026 at Nexalin Technology, down from -$2.1 million in the prior quarter.
  • The five-year high for Operating Income was -$293194.0 in Q3 2022, with the low at -$2.9 million in Q4 2024.
  • Average Operating Income over 5 years is -$1.6 million, with a median of -$1.6 million recorded in 2023.
  • The sharpest annual moves came in 2022 and 2023: Operating Income surged 83.67% in 2022, then slumped 723.87% in 2023.
  • Over 5 years, Operating Income stood at -$719617.0 in 2022, then slumped by 125.74% to -$1.6 million in 2023, then slumped by 77.0% to -$2.9 million in 2024, then advanced by 16.08% to -$2.4 million in 2025, then gained by 6.87% to -$2.2 million in 2026.
  • The last three Operating Income figures came in at -$2.2 million (Q2 2026), -$2.1 million (Q1 2026), and -$2.4 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Abbott Laboratories 180.55 Bn 174.95 Bn 7.27 Bn 1.69 Bn
2 Intuitive Surgical 128.01 Bn 122.80 Bn 1.96 Bn 971.90 Mn
3 Medtronic 117.17 Bn 108.35 Bn 6.34 Bn 1.76 Bn
4 Stryker 104.15 Bn 100.67 Bn 4.50 Bn 1.66 Bn
5 Boston Scientific 63.37 Bn 62.83 Bn 3.85 Bn 1.18 Bn
6 Edwards Lifesciences 49.75 Bn 45.50 Bn 1.35 Bn 513.20 Mn
7 Alcon 33.01 Bn 31.55 Bn 1.68 Bn 11.00 Mn
8 Dexcom 32.16 Bn 30.22 Bn 830.00 Mn 318.30 Mn
9 Steris 20.74 Bn 20.25 Bn 684.20 Mn 285.80 Mn
10 Nexalin Technology 3.42 Mn 2.41 Mn 8,897.00 -2.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.25 Mn
Mar 31, 2026 -2.12 Mn
Dec 31, 2025 -2.41 Mn
Sep 30, 2025 -2.35 Mn
Jun 30, 2025 -1.62 Mn
Mar 31, 2025 -2.01 Mn
Dec 31, 2024 -2.88 Mn
Sep 30, 2024 -2.51 Mn
Jun 30, 2024 -1.30 Mn
Mar 31, 2024 -1.07 Mn
Dec 31, 2023 -1.62 Mn
Sep 30, 2023 -2.42 Mn
Jun 30, 2023 -876,860.00
Mar 31, 2023 -779,426.00
Dec 31, 2022 -719,617.00
Sep 30, 2022 -293,194.00
Jun 30, 2022 -445,103.00
Mar 31, 2022 -375,117.00
Dec 31, 2021 -577,489.00
Sep 30, 2021 -1.80 Mn